Optimising anticoagulants for older persons with atrial fibrillation

Debbie Rigby 01/07/2025

Optimising therapy for the increasing population of older adults with atrial fibrillation (AF) is challenging. AF is associated with a 5-fold risk of stroke and systemic embolism.1 To mitigate these risks, direct oral anticoagulants (DOACs) are recommended therapy for people living with AF. DOACs present several challenges when used in older persons with atrial fibrillation. By

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Email
This field is for validation purposes and should be left unchanged.
Has the fuel crisis changed how you get around?*
- I’m taking public transport to work more often
- I’m taking public transport between work sites (eg community pharmacy and aged care) more often
- Colleagues and I are carpooling
- We are cutting back (or considering cutting back) on medicines deliveries
- We have stopped (or are considering stopping) medicines deliveries
- I am sticking closer to home when performing medicines reviews
- I would like to reduce pharmacy-related fuel consumption but it’s not feasible
- No change